MXiPr

3-MeO-2′-Oxo-PCiPr (also known as MXiPr) is a novel dissociative substance of the arylcyclohexylamine class. It is a structural analog of MXE. The mechanism of action is not known, but it is likely an NMDA receptor antagonist, producing dissociative and euphoric effects.

Also known as: Mxip, Methoxipropamine, Methoxisopropylamine

Classification

Chemical: Arylcyclohexylamine
Psychoactive: Dissociative

Effects

Numbness
Somatic Lightness
Sedation
Stimulation
Loss Of Balance
Incoordination
Euphoria
Depersonalization
Time Dilation
Memory Impairment
Disconnection
Dizziness
Blurred Vision
Increased Music Appreciation
Auditory Distortion
Open Eye Visuals
Closed Eye Visuals
Warping

Routes of Administration

Insufflated

Dosage

Threshold: 5 mg
Heavy: 60+ mg
Common: 20-40 mg
Light: 10-20 mg
Strong: 40-60 mg

Duration

Onset: 0.15-0.5 h
After Effects: 2.5-4 h
Peak: 0.5-1.5 h
Offset: 2-2.5 h
Total Duration: 2-2.5 h

Oral

Dosage

Threshold: 5 mg
Heavy: 60+ mg
Common: 20-40 mg
Light: 10-20 mg
Strong: 40-60 mg

Duration

Onset: 0.3-0.67 h
After Effects: 4-48 h
Peak: 0.75-2 h
Offset: 2.5-4 h
Total Duration: 3-5 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

psychonautwiki.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu